Most Recent Articles by Hannah Dellabella
In patients with Parkinson disease psychosis, treatment with pimavanserin has a lower risk for mortality compared with quetiapine or combination therapy.
Investigators assessed the safety and tolerability of once-monthly aripiprazole 400 mg in patients with bipolar disorder I who were already stabilized on oral aripiprazole.
Efficacy of asenapine was not associated with the type of current episode, stage of disease progression, or baseline body weight.
In addition to a better work-life balance, concierge medicine can reduce the number of patients a physician needs to see in order to make a living.
Investigators examine whether volumetric changes on MRI can predict daily-life function in patients with bipolar disorder.
More Articles by Hannah Dellabella
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Efficacy, Safety of Long-Term Ketamine Administration Still In Question
- Etiology of Schizophrenia: Strong Association With Certain Rare Copy Number Variants
- KCNQ Channel Potentiator Ezogabine Delivers Promising Results in Major Depressive Disorder
- Vulnerability to Psychosocial Disability in Psychosis
- FDA to Review Lumateperone for Treatment of Schizophrenia
- Cannabis Use, Cannabis Use Disorder Linked to Psychotic, Depressive Symptoms
- Abstinence From Regular Cannabis Use Improves Memory Among Adolescents, Young Adults
- Association Between Opioid and Benzodiazepine Misuse and Suicidal Ideation
- Group Cognitive Behavioral Therapy Is Effective Treatment for Adolescent Anxiety
- The Intersection of Eating and Alcohol Disorders: Detecting and Managing "Drunkorexia"